Prenetics discloses terms of $1 billion IM8 financing with General Catalyst fund

Prenetics Global Limited filed a Form 6-K dated for the month of August 2026, noting that on July 14, 2026, the company announced the closing of a $1 billion growth financing arrangement with General Catalyst's Customer Value Fund for the company's IM8 business.¹ The filing includes an exhibit of risk factors tied to the deal, plus copies of the underlying agreements.

Under the arrangement, Prenetics' wholly-owned subsidiary IM8 (US) LLC entered into the Customer Investment Agreement with GC Customer Value Arranger, LLC, acting on behalf of certain investors, with Prenetics Limited and IM8 Limited serving as guarantors, to fund IM8's sales and marketing growth efforts.¹ The arranger will facilitate funding of up to an aggregate maximum of $1,000,000,000.¹ The commitment period runs through August 11, 2028, subject to mutual extension by the parties.¹

The structure calls for the arranger to fund up to 70% of IM8's monthly growth spend, after which IM8 must remit to the arranger a share of collections from customers acquired that month until the investor return cap is reached or 10 years pass, whichever comes first.¹ That cap is set so investors would not exceed a 30% internal rate of return across all cohorts funded in a given calendar year, or alternatively a return multiple tied to the investment amount ranging from 1.035x up to 1.170x, whichever is lower.¹

The deal is backed by a Master Guarantee Agreement dated July 13, 2026, under which IM8 Limited and Prenetics Limited jointly and severally guarantee payment and performance of obligations under the Customer Investment Agreement.¹ The company also disclosed that the Customer Investment Agreement restricts its ability to take on new debt unless it gets the arranger's approval or arranges an intercreditor or subordination agreement acceptable to the arranger.¹

Prenetics warned that there is no guarantee the financing structure will succeed in acquiring new customers or meeting its intended goals, and failure to do so could hurt its financial condition and results.¹ The report was signed by Chief Executive Officer Danny Sheng Wu Yeung on August 7, 2026.